To confirm their identity, firstly we performed IHC with standard immune cell markers (CD45, CD68, and CD8) and S100A9 on tumor sections, distinguishing tumor core and necrotic areas (Figure 4A–E). This evidence concerns the gene CD8A and neoplasm.